MAR-ABIRATERONE

marcan pharmaceuticals inc🇨🇦 Health Canada

Approval Id: 88b8c33bdb940f41
Drug Approval Canada Name: MAR-ABIRATERONE
Product Name: MAR-ABIRATERONE
Status: Marketed
Status Date: 2021-02-03
Original Market Date: 2021-02-03
Din: 02503999
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L02BX03 ABIRATERONE
Atc Name: l 02 bx 03
Aig Number: 0152948002
Company Name: marcan pharmaceuticals inc
Company Address: 2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2

ABIRATERONE ACETATE

500 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

88b8c33bdb940f41

Type

Standard